An evaluation of known predictive biomarkers for gastric cancer.

INTRODUCTION: Gastric cancer (GC) is the fifth most common malignancy worldwide and it is associated with a poor prognosis, with most cases diagnosed at an advanced stage. In the advanced/metastatic setting, targeted treatments are assuming an increa…

Preview only. Read the full abstract at the source